Marksans Pharma consolidated net profit rises 30.73% in the September 2019 quarter
Sales decline 4.70% to Rs 256.40 crore
Net profit of Marksans Pharma rose 30.73% to Rs 25.65 crore in the quarter ended September 2019 as against Rs 19.62 crore during the previous quarter ended September 2018. Sales declined 4.70% to Rs 256.40 crore in the quarter ended September 2019 as against Rs 269.04 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales256.40269.04 -5 OPM %13.0913.80 -PBDT38.6433.26 16 PBT33.6627.72 21 NP25.6519.62 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2019 | 3:20 PM IST